^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Labcorp® Plasma Complete™

Company:
LabCorp
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
PGDx elio™ plasma complete analyzes circulating tumor DNA for genetic alterations in cancer, eliminating the need for an invasive biopsy or tumor tissue. PGDx elio plasma complete evaluates a comprehensive panel of 521 genes. Cell-free DNA (cfDNA) is extracted from plasma and prepared using proprietary methods that accommodate low abundance sample DNA.
Cancer:
Solid Tumor
Gene:
ABL1 (ABL proto-oncogene 1), ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase), AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase)
See More ...
Method:
Next-Generation Sequencing (NGS)